Mar 21 2020

Pharmaceutical Commerce Magazine, For Pharma Industry Executives, pharmaceutical positions.

#Pharmaceutical #positions

Pharmaceutical positionsPharmaceutical positions

Pharmaceutical positions

Pharmaceutical positions

Pharmaceutical positions

Latest News

Pharmaceutical positions

Pharmaceutical positions

Pharmaceutical positions


A conversation with Jim Cleary, AmerisourceBergen

AmerisourceBergen, No. 11 on the Fortune 500, is one of the Big Three drug wholesalers in the US, and positions itself as a provider of “innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout

First physicians, now patients: Risk avoidance in patient support programs

In this new age of patient centricity, the focus of the pharmaceutical industry is starting to shift from developing relationships with healthcare providers to establishing services and solutions around the patient. This shift arises from the complexities of disease states

Pre-approval access and real-world evidence: a win-win proposition

The introduction of new therapies coupled with a sense of entitlement to them continues to generate great interest in earlier access to experimental medicines. Generating real-world evidence from pre-approval access programs could present a win-win situation for all stakeholders involved.

Big Pharma requires big help in protecting CRT products

Meeting the challenges of ensuring product integrity, while keeping control of transportation costs, is a common responsibility for life sciences supply chain managers. This responsibility requires a finger on the pulse of both equipment cost and availability, combined with a

Traceability end-of-year update

At the beginning of this year, Pharmaceutical Commerce called 2017 “Year Zero” in the march toward end-to-end pharma traceability. The ostensible reason was that November 2017 was to be the date when effectively all new pharmaceutical packages entering US commercial [ ]

Written by admin